In Vitro Newly Isolated Environmental Phage Activity against Biofilms Preformed by Pseudomonas aeruginosa from Patients with Cystic Fibrosis
Open Access
- 25 February 2021
- journal article
- research article
- Published by MDPI AG in Microorganisms
- Vol. 9 (3), 478
- https://doi.org/10.3390/microorganisms9030478
Abstract
As disease worsens in patients with cystic fibrosis (CF), Pseudomonas aeruginosa (PA) colonizes the lungs, causing pulmonary failure and mortality. Progressively, PA forms typical biofilms, and antibiotic treatments determine multidrug-resistant (MDR) PA strains. To advance new therapies against MDR PA, research has reappraised bacteriophages (phages), viruses naturally infecting bacteria. Because few in vitro studies have tested phages on CF PA biofilms, general reliability remains unclear. This study aimed to test in vitro newly isolated environmental phage activity against PA isolates from patients with CF at Bambino Gesù Children’s Hospital (OBG), Rome, Italy. After testing in vitro phage activities, we combined phages with amikacin, meropenem, and tobramycin against CF PA pre-formed biofilms. We also investigated new emerging morphotypes and bacterial regrowth. We obtained 22 newly isolated phages from various environments, including OBG. In about 94% of 32 CF PA isolates tested, these phages showed in vitro PA lysis. Despite poor efficacy against chronic CF PA, five selected-lytic-phages (Φ4_ZP1, Φ9_ZP2, Φ14_OBG, Φ17_OBG, and Φ19_OBG) showed wide host activity. The Φ4_ZP1-meropenem and Φ14_OBG-tobramycin combinations significantly reduced CF PA biofilms (p < 0.001). To advance potential combined phage-antibiotic therapy, we envisage further in vitro test combinations with newly isolated phages, including those from hospital environments, against CF PA biofilms from early and chronic infections.Keywords
Funding Information
- Bambino Gesù Children's Hospital IRCCS (201402Q003211; 201602P003765; 201702P004054)
This publication has 39 references indexed in Scilit:
- Total Protein Analysis as a Reliable Loading Control for Quantitative Fluorescent Western BlottingPLOS ONE, 2013
- Back to the future: evolving bacteriophages to increase their effectiveness against the pathogen Pseudomonas aeruginosa PAO1Evolutionary Applications, 2013
- The Susceptibility of Pseudomonas aeruginosa Strains from Cystic Fibrosis Patients to BacteriophagesPLOS ONE, 2013
- Novel approaches to the treatment ofPseudomonas aeruginosainfections in cystic fibrosisEuropean Respiratory Journal, 2012
- Bacteriophages ϕMR299-2 and ϕNH-4 Can Eliminate Pseudomonas aeruginosa in the Murine Lung and on Cystic Fibrosis Lung Airway CellsmBio, 2012
- Pulmonary Bacteriophage Therapy on Pseudomonas aeruginosa Cystic Fibrosis Strains: First Steps Towards Treatment and PreventionPLOS ONE, 2011
- Characterization of JG024, a pseudomonas aeruginosa PB1-like broad host range phage under simulated infection conditionsBMC Microbiology, 2010
- Molecular characterization of Legionella pneumophila-induced interleukin-8 expression in T cellsBMC Microbiology, 2010
- Pseudomonas aeruginosa biofilm formation in the cystic fibrosis airwayPulmonary Pharmacology & Therapeutics, 2007
- Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patientsProceedings of the National Academy of Sciences, 2006